Insiders · ACXP

ACXP insider transactions

Acurx Pharmaceuticals Inc. (ACXP) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

ACXP insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Acurx Pharmaceuticals Inc., latest first. Follow anyone to get their next filing.

• Carl SailerDirector+$200K
• Jack H DeanDirector+$10,000
• James J. DonohueDirector+$10,000
• Joseph C ScodariDirector+$25K
• Thomas L HarrisonDirector
• Robert J DelucciaDirector+$150K
• David P LuciPresident and CEO, Director+$150K
• Robert G. ShawahChief Financial Officer

Recent Form 3, 4, and 5 filings for ACXP

• 201d
  SEC Form 4 filed by Sailer Carl

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 201d
  SEC Form 4 filed by Dean Jack H

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 201d
  SEC Form 4 filed by Donohue James J.

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 201d
  SEC Form 4 filed by Harrison Thomas L

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 201d
  SEC Form 4 filed by Scodari Joseph C

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 201d
  SEC Form 4 filed by Deluccia Robert J

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 201d
  SEC Form 4 filed by Luci David P

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 201d
  SEC Form 4 filed by Shawah Robert G.

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 641d
  SEC Form 4 filed by Chief Financial Officer Shawah Robert G.

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 641d
  SEC Form 4 filed by President and CEO Luci David P

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 641d
  SEC Form 4 filed by Director Deluccia Robert J

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 670d
  Director Scodari Joseph C bought $25,000 worth of shares (24,631 units at $1.01), increasing direct ownership by 800% to 27,708 units (SEC Form 4)

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 670d
  Director Sailer Carl bought $25,000 worth of shares (24,631 units at $1.01), increasing direct ownership by 22% to 137,183 units (SEC Form 4)

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 670d
  President and CEO Luci David P bought $50,000 worth of shares (49,261 units at $1.01), increasing direct ownership by 5% to 1,097,458 units (SEC Form 4)

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 670d
  Director Donohue James J. bought $10,000 worth of shares (9,852 units at $1.01), increasing direct ownership by 79% to 22,352 units (SEC Form 4)

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 670d
  Director Deluccia Robert J bought $50,000 worth of shares (49,261 units at $1.01), increasing direct ownership by 5% to 1,010,196 units (SEC Form 4)

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 670d
  Director Dean Jack H bought $10,000 worth of shares (9,852 units at $1.01), increasing direct ownership by 83% to 21,776 units (SEC Form 4)

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 874d
  SEC Form 4 filed by Director Scodari Joseph C

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 874d
  SEC Form 4 filed by Director Sailer Carl

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 874d
  SEC Form 4 filed by Director Harrison Thomas L

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 874d
  SEC Form 4 filed by Director Donohue James J.

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 874d
  SEC Form 4 filed by Director Dean Jack H

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 950d
  SEC Form 4 filed by Shawah Robert G.

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 950d
  SEC Form 4 filed by Luci David P

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 950d
  SEC Form 4 filed by Deluccia Robert J

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1022d
  Sailer Carl exercised 19,737 shares at a strike of $3.55, increasing direct ownership by 21% to 112,552 units (SEC Form 4)

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1040d
  Deluccia Robert J gifted 110,000 shares and exercised 19,737 shares at a strike of $3.55, decreasing direct ownership by 9% to 960,935 units (SEC Form 4)

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1040d
  Luci David P exercised 19,737 shares at a strike of $3.55, increasing direct ownership by 2% to 1,048,197 units (SEC Form 4)

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1242d
  SEC Form 4 filed by Donohue James J.

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1242d
  SEC Form 4 filed by Harrison Thomas L

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1242d
  SEC Form 4 filed by Sailer Carl

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1242d
  SEC Form 4 filed by Dean Jack H

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1242d
  SEC Form 4 filed by Scodari Joseph C

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1354d
  SEC Form 4 filed by Luci David P

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1354d
  SEC Form 4 filed by Shawah Robert G.

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1354d
  SEC Form 4 filed by Deluccia Robert J

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1564d
  SEC Form 4: Sailer Carl bought $75,001 worth of shares (19,737 units at $3.80), increasing direct ownership by 27% to 92,815 units

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1564d
  SEC Form 4: Deluccia Robert J bought $75,001 worth of shares (19,737 units at $3.80), increasing direct ownership by 2% to 1,051,198 units

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1564d
  SEC Form 4: Luci David P bought $75,001 worth of shares (19,737 units at $3.80), increasing direct ownership by 2% to 1,028,460 units

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1811d
  SEC Form 4: Sailer Carl bought $24,979 worth of shares (5,161 units at $4.84), increasing direct ownership by 8% to 73,078 units

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1813d
  SEC Form 4: Deluccia Robert J bought $24,672 worth of shares (5,034 units at $4.90), increasing direct ownership by 0.49% to 1,031,461 units

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1813d
  SEC Form 4: Luci David P bought $24,960 worth of shares (5,200 units at $4.80), increasing direct ownership by 0.52% to 1,008,723 units

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1886d
  SEC Form 4: Sailer Carl bought $75,000 worth of Common Stock (12,500 units at $6.00), increasing direct ownership by 23% to 67,917 units

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)